Janssen Infectious Diseases BVBA

1 in Phase 3

Quick facts

Phase 3 pipeline

Rilpivirine (RPV) · Infectious Diseases
Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that blocks the replication of HIV-1 by binding to the reverse transcriptase enzyme.

Phase 1 pipeline

Aged RPV-LA

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: